Navigation Links
Drugs in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... advancing our large and growing pipeline of 19 drugs in development. Our partnership strategy not only allows our drugs to move forward effectively toward the market but ... 2009; clinical trials already initiated on three drugs this year Expand pipeline by moving at ...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

... - Program Focuses on Expanding Pipeline of drugs For People with Type 1 Diabetes - NEW ... to speed the translation of basic research into drugs and treatments for type 1 diabetes," said Alan J. ... with a proven track record of delivering drugs to the clinic to address a critical gap in ...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

... chemically, but this evidence shows that these drugs are putting women in New Jersey and across the ... the largest study to-date looking at how these drugs impact breast cancer recurrence rates when taken ... and Zoloft are among a group of antidepressant drugs known as CYP2D6 inhibitors. ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... for patients who are likely to need multiple drugs to achieve their blood pressure goals. Tekturna ... or if you have allergic reactions to certain drugs known as sulfonamides. If you are taking TEKTURNA ... and markets leading innovative prescription drugs used to treat a number of diseases and ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... drug and the first in a new class of drugs called BLyS-specific inhibitors. No new drug for ... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ...

Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity

... investigating the unique abilities of their drugs to safely and effectively treat menopausal ... This is particularly important when developing drugs that mediate their effects through estrogen ... have been endeavoring to develop more selective drugs in women's health, and Dr. Leitman's study ...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... patients. Unlike other classes of HIV drugs that work to inhibit viral replication within ... HIV-infected individuals is to combine three drugs from two classes to initiate antiretroviral ... a more favorable lipid safety profile than other drugs in the PI class. The study is being ...

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

... Addiction to and abuse of prescription opioid drugs are prevalent, and they exact an immense toll on ... Unmet Needs, Risks, and Solutions." Opioid drugs have been used by humans for thousands of years ... coupled with the feeling of euphoria these drugs can produce, leads to abuse. According to ....

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... are taken to help people take their prescription drugs properly. Commonly referred to as ... result of Americans not taking their prescription drugs properly is a well-documented phenomenon that ... reasons why people don't take their prescription drugs properly," notes HCPC Executive Director Peter G. ...

Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells

... (DGS), the Company is working to develop new drugs and diagnostic agents to treat many types of ... platform makes it possible to use highly-potent drugs on extended and frequent dosing schedules and in combination with other drugs to maximize efficacy. The technology improves ...

New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases

... in clinical studies. Researchers developing drugs to treat rare diseases struggle to recruit ... cystic fibrosis (CF). More than 30 promising CF drugs are in development, yet only about 30,000 people ... this new legislation clears the way for promising drugs to move more swiftly from the research phase into ...

Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

... ISIS ) announced today that Isis' antisense drugs were highlighted with eight presentations ... reducing levels of these targets with antisense drugs can significantly lower blood glucose levels and ... drug discovery program showing antisense drugs reduced fat mass and body weight in animals by ...

Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual

... deliver significantly higher doses of anti-cancer drugs to a patient's liver while preventing entry of the drugs to the rest of the patient's circulation. This ... the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... study shed new light on a different class of drugs that faced increased scrutiny from the US Food ... Medco chief medical officer. "Knowing which drugs work for which individuals with diabetes will ... patients not taking TZDs. TZDs -- a class of drugs used to control blood sugar -- are used by as ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... or FDA, draft guidance for the development of drugs for weight management. "These data provide ... recommendations regarding the development of drugs for the indication of weight management. It ... discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, ...

IBM and EU Partners Create a Better Way to Fight AIDS Virus

... smarter and more efficient way to choose the best drugs combinations for any given HIV genetic variant. ... is dependant on choosing the right combination of drugs that work for the longest period of time. ... improves prediction of the right combination of drugs that works for the maximum amount of time." These ...

Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)

... announced today that the FDA's Anti-Infective drugs Advisory Committee voted in the majority that ... in CAP. The FDA has established a Prescription drugs User Fee Act (PDUFA) date of July 31, 2009 for ... development and commercialization of novel drugs in the therapeutic areas of infection, cancer, ...

Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain

... such as ibuprofen, are among the most widely used drugs in the world," said Loren Laine, MD, professor of ... such as ibuprofen, are among the most widely used drugs in the world for the treatment of chronic pain ... adults. NSAIDs are among the most widely used drugs in the world for the treatment of arthritis and ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

... - Nearly 30 percent of tamoxifen users take drugs that reduce its effectiveness against breast ... is the largest study to date looking at how these drugs impact breast cancer recurrence rates when taken ... Zoloft(R) (sertraline), and are among a group of drugs known as CYP2D6 inhibitors. Antidepressants are ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... IMPORTANT SAFETY INFORMATION Like other drugs with mu-opioid activity, NUCYNTA(TM) is ... sedation, coma or death may result if these drugs are taken in combination with NUCYNTA(TM). When ... and is a Schedule II controlled substance. Such drugs are sought by drug abusers and people with ...

Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)

... requirement for establishing the efficacy of new drugs used to counter bioterrorism. The submission ... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ...

RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed the Time to Relapse in Patients with Bipolar I Disorder

... psychosis treated with antipsychotic drugs are at an increased risk of death compared to ... psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 ... drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the ...

Mutant Genes in High-Risk Childhood Leukemias Identified

... relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood ... "What's more, in test tube studies, we found that drugs blocking the activation of the mutant JAK kinases ...

Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy

... alliances that further our goal of developing drugs for adrenergic regulation," said Steve Butts, ... trials in three years. Each of Addrenex's drugs in development focuses on the treatment of ... hypertension. The company also plans to develop drugs to treat menopausal flushing and potentially ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... Abuse (NIH-NIDA) in an effort to discover novel drugs to treat cocaine abuse. In 2002, Wentland's NIH ... smoothly. In the last 39 years I have had many drugs enter the clinic and then fail. And now I'm here ... well as identify back-up and/or second-generation drugs for possible application to other diseases. ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system ... or hypersensitivity to other sulfonamide derived drugs Fetal/Neonatal Morbidity and Mortality ... that allows for continuous development of novel drugs that enrich the quality of life for patients ...

FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia

... to larger elevations seen with some other drugs in this class. Fanapt(TM) has a low ... events that are often associated with some other drugs in the class of atypical antipsychotics. Similarly to some other drugs in this class, Fanapt(TM) may affect heart rhythm ...

Isis and Collaborators Present New Research at the ATVB Annual Conference

... profile in mice" demonstrating that antisense drugs that inhibit Factor XI can prevent thrombus ... of significant advances in creating antisense drugs that can more safely reduce undesired clotting. ... power of our antisense technology to develop new drugs to nearly any genomic target," said Brett Monia, ...

Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C

... for the observed SVR difference between the two drugs in the ACHIEVE 2/3 study. In ... alfa-2a. The causes of discontinuation for both drugs were those typical for interferon-based therapy. ... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS ...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

... revealing that a combination of FDA-approved drugs works synergistically to help children with acute ... Dr. Ge and fellow researchers considered drugs that are already FDA-approved to help fight AML. ... used to treat epilepsy. They found the two drugs worked together to dramatically stimulate cell ...

Strativa Pharmaceuticals Provides Product Pipeline Update

... Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for ... proprietary PharmFilm(R) technology to deliver drugs in quick dissolving films. PharmFilm(R) is ... markets while offering unique advantages over drugs dosed by traditional tablets, capsules and orally ...

Parkinson's Disease Medication Triggers Destructive Behaviors

... patients receiving therapeutic doses of certain drugs for Parkinson's disease develops new-onset, ... Dopamine agonists are a class of drugs that include pramipexole and ropinirole. They are ... disease. Of those 66, 38 were taking the drugs in therapeutic doses (doses expected to be at ...

AHRQ-Funded Study Finds Lower Risk of Death and Heart Attack in Patients With Drug-Coated Stent Implants Compared to Those With Bare Metal Stents

... Administration approved two stents coated with drugs in 2003 and 2004, but then issued precautionary ... discharge and may receive prescriptions for drugs and therapies to lower their cholesterol levels ... post-implantation treatment with blood-thinning drugs such as clopidogrel. The study, "Clinical ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... designation allows FDA to expedite review of drugs and biologics for serious or life-threatening ... is the most potent activator of platelets. drugs that block platelet activation by other ... therefore a member of a potentially new class of drugs called thrombin receptor antagonists. ...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...

Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)

... as the global population ages. Currently marketed drugs transiently affect some of the symptoms of the disease, but there are no drugs on the market today that slow or arrest the progression of the disease. These symptomatic drugs are projected to generate more than US $6 billion ...

Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)

... can potentially create new small molecule drugs with optimal physicochemical and pharmacological ... States alone. Currently, there are no oral drugs approved that are indicated to treat OIC. OBD ... of clinical trials and commercial launch of new drugs may be delayed or unsuccessful due to regulatory ...

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...

Research Finding Could Revolutionize Asthma Treatment

... suggesting that, contrary to popular belief, drugs commonly used to treat high blood pressure may ... panel recommended that the FDA ban two inhaled drugs for use in asthma, because studies had shown an ... and asthma-related deaths. Notably, these two drugs have the opposite effect of beta blockers. ...

Dr. James F. Pingpank to Present at Leading Regional Therapies Conference

... deliver significantly higher doses of anti-cancer drugs to a patient's liver while preventing entry of the drugs to the rest of the patient's circulation. This ... the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of ...
Other Contents
(Date:7/11/2014)... is evidence that under the normal circumstances, ... development, maintain neuronal environment, and exhibit therapeutic ... neurodegenerative disease. Previous studies have found that ... after chemical induction have reduced viability, which ... Prof. Xiaodong Yuan, Kailuan General Hospital, Hebei ...
(Date:7/11/2014)... the proteins that let nerve cells send out electrical ... a biological tactic that may offer a new way ... and environmentally responsible way. , Their findingthat naturally ... and harmless for a closely related onesuggests that insecticides ... beneficial species like bees. A summary of the research, ...
(Date:7/10/2014)... , June 27, 2014  The American Academy ... Institute of Standards and Technology (NIST) and the ... academic research and forensic science expert members to ... is an element of the NIST,s Organization of ... among the first appointments made to the new ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3
(Date:7/11/2014)... 11, 2014 As part of ... Liebhard LLP has been closely monitoring the ongoing ... (FDA) Obstetrics and Gynecology Devices Panel, which ... the cancer risks associated with the use of ... to a report published by Dow Jones Business ...
(Date:7/11/2014)... July 11, 2014 Operators ... $50 billion in fuel costs now that ... current GHG standards are phasing ... it upon themselves to install new features ... 1.    Idle reduction technologies , 2.    Efficient driveline components ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... Supplements, Specialty Nutrients, Animal Feed), Applications (Regular, Therapeutic, ... - Global Trends & Forecasts to 2019 ” ... an analysis and forecasting of the market value ... identifies the driving and restraining factors for the ...
(Date:7/11/2014)... disposable medical suppliers call for the biggest share of ... past two decades, the world market for disposable medical ... year), primarily owing to the importance of these products ... market for disposable medical supplies in the world, accounting ... held by Europe with a 29% market share. The ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... five years to 2014 on the heels of fresh ... prompted farmers to dedicate a larger share of their ... More specifically, the regulations required the mixing of 5.0% ... biofuel production in the United States created a key ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3
Other TagsOther Tags